In the Wegovy-pill clinical trial, 18% of people who received the medication discontinued the treatment, which was less than the 26% rate in the placebo group
Atherosclerosis 212(1):223229 Tsuboi N, Okabayashi Y, Shimizu A, Yokoo T (2017) The renal pathology of obesity
Journal of Clinical Endocrinology & Metabolism (1994) The insulin-like growth factor system and its pleiotropic fu
Difficulty Walking and Balance Issues: Severe deficiency may lead to problems with coordination and walking
For what to expect after conception, our piece on PCOS pregnancy rate covers the metabolic considerations that come up in the first trimester
Patients unable to tolerate gastrointestinal side effects: While most patients adjust, some cannot tolerate the nausea and other GI effects